A new clinical trial will test three drugs concurrently to find treatments for progressive supranuclear palsy (PSP), a rare and fatal neurodegenerative disorder. The trial aims to slow the relentless progression of PSP, which currently has no cure.
You May Also Like
Are Smokers Really Less Likely to Develop Parkinson’s?
September 8, 2024
Tau Levels Predict Memory Loss in Alzheimer’s
September 7, 2024
Upper GI Damage Linked to 76% Higher Parkinson’s Disease Risk
September 7, 2024
More From Author
Complex needs shelter wins praise from Regina police, addiction experts
September 15, 2024
Victoria police chief wants more powers for hospital security
September 14, 2024
+ There are no comments
Add yours